Evoke Pharma (EVOK)
NASDAQ:EVOK
Holding EVOK?
Track your performance easily

Evoke Pharma (EVOK) Financial Statements

445 Followers

Evoke Pharma Financial Overview

Evoke Pharma's market cap is currently ―. The company's EPS TTM is $-16.23; its P/E ratio is -0.26; Evoke Pharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.55M$ 1.74M$ 1.68M$ 1.56M$ 1.13M
Gross Profit$ 2.55M$ 1.74M$ 1.68M$ 1.56M$ 1.13M
EBIT$ -1.14M$ -1.36M$ -1.74M$ -1.50M$ -1.63M
EBITDA$ -1.14M$ -1.36M$ -1.74M$ -1.50M$ -1.63M
Net Income Common Stockholders$ -1.27M$ -1.58M$ -1.99M$ -1.62M$ -1.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.20M$ 9.70M$ 4.70M$ 6.00M$ 7.00M
Total Assets$ 12.14M$ 12.45M$ 7.07M$ 7.85M$ 8.97M
Total Debt$ 5.00M$ 5.00M$ 5.00M$ 5.01M$ 5.05M
Net Debt$ -4.20M$ -4.70M$ 300.00K$ -986.63K$ -1.95M
Total Liabilities$ 9.47M$ 8.96M$ 9.65M$ 8.73M$ 8.44M
Stockholders Equity$ 2.66M$ 3.50M$ -2.58M$ -873.77K$ 538.37K
Cash Flow-
Free Cash Flow$ -820.62K$ -2.58M$ -1.11M$ -1.04M$ -1.21M
Operating Cash Flow$ -820.62K$ -2.58M$ -1.11M$ -1.04M$ -1.21M
Investing Cash Flow-----
Financing Cash Flow$ 295.70K$ 7.54M$ -119.30K--
Currency in USD

Evoke Pharma Earnings and Revenue History

Evoke Pharma Debt to Assets

Evoke Pharma Cash Flow

Evoke Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis